The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion

Journal of Clinical Investigation

Volumn 105, Issue 5, 2000, Pages 683-691

  Siegelman, Mark H ^a   Stanescu, Diana ^a   Estess, Pila ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; HERMES ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 0034116088     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8692     Document Type: Article

References (63)

1. Butcher, E.C., and Picker, L.J. 1996. Lymphocyte homing and homeostasis. Science. 272:60-66.
2. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301-314.
3. Kansas, G.S. 1996. Selectins and their ligands: current concepts and controversies. Blood. 88:3259-3287.
4. Carlos, T.M., and Harlan, J.M. 1994. Leukocyte-endothelial adhesion molecules. Blood. 84:2068-2101.
5. Mackay, C.R. 1991. T-cell memory: the connection between function, phenotype and migration pathways. Immunol. Today. 12:189-192.
6. Koster, F.T., and McGregor, D.D. 1971. The mediator of cellular immunity. III. Lymphocyte traffic from the blood into the inflamed peritoneal cavity. J. Exp. Med. 133:864-876.
7. Guy, G.D., Griscelli, C., and Vassalli, P. 1978. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-vs.-host conditions. J. Exp. Med. 148:1661-1677.
8. Issekutz, T.B. 1991. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A likely role for VLA-4 in vivo. J. Immunol. 147:4178-4184.
9. Austrup, F., et al. 1997. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature. 385:81-83.
10. DeGrendele, H.C., Estess, P., Picker, L.J., and Siegelman, M.H. 1996. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte/endothelial cell primary adhesion pathway. J. Exp. Med. 183:1119-1130.
11. Lesley, J., Howes, N., Perschl, A., and Hyman, R. 1994. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 180:383-387.
12. DeGrendele, H.D., Estess, P., and Siegelman, M.H. 1997. Requirement for CD44 in activated T cell extravasation into an inflamed site. Science. 278:672-675.
13. DeGrendele, H.C., Estess, P., and Siegelman, M.H. 1997. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J. Immunology. 159:2549-2553.
14. Haynes, B.F., Hale, L.P., Patton, K.L., Martin, M.E., and McCallum, R.M. 1991. Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum. 34:1434-1443.
15. Estess, P., DeGrendele, H.C., Pascual, V., and Siegelman, M.H. 1998. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. J. Clin. Invest. 102:1173-1182.
16. Mikecz, K., Brennan, F.R., Kim, J.H., and Glant, T.T. 1995. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat. Med. 1:558-563.
17. Verdrengh, M., Holmdahl, R., and Tarkowski, A. 1995. Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen 11 arthritis. Scand. J. Immunol. 42:353-358.
18. Brocke, S., Piercy, C., Steinman, L., Weissman, I.L., and Veromaa, T. 1999. Antibodies to CD44 and integrin alpha(4), but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. USA. 96:6896-6901.
19. Knoflach, A., et al. 1999. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model. J. Am. Soc. Nephrol. 10:1059-1066.
20. Knoflach, A., et al. 1999. Immunomodulatory functions of hyaluronate in the LEW-to-F344 model of chronic cardiac allograft rejection. Transplantation. 67:909-914.
21. Hathcock, K.S., Hirano, H., Murakami, S., and Hodes, R.J. 1993. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid. J. Immunol. 151:6712-6722.
22. Katoh, S., Zheng, Z., Oritani, K., Shimozato, T., and Kincade, P.W. 1995. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182:419-429.
23. Lesley, J., English, N., Perschl, A., Gregoroff, J., and Hyman, R. 1995. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 182:431-437.
24. Bennett, K.L., et al. 1995. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol. 131:1623-1633.
25. Bartolazzi, A., Nocks, A., Aruffo, A., Spring, F., and Stamenkovic, I. 1996. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol. 132:1199-1208.
26. Goldstein, L.A., et al. 1989. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell. 56:1063-1072.
27. Mohamadzadeh, M., DeGrendele, H.C., Estess, P., and Siegelman, M.H. 1998. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA dependent primary adhesion. J. Clin. Invest. 101:97-108.
28. Cannistra, S.A., et al. 1993. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res. 53:3830-3838.
29. Kansas, G.S., Wood, G.S., and Dailey, M.O. 1989. A family of cell-surface glycoproteins defined by a putative anti-endorhelial cell receptor antibody in man. J. Immunol. 142:3050-3057.
30. Clayberger, C., et al. 1987. Identification and characterization of two novel lymphocyte function-associated antigens, L24 and L25. J. Immunol. 138:1510-1514.
31. Alon, R., et al. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1243-1253.
32. Lesley, J., Schulte, R., and Hyman, R. 1990. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp. Cell Res. 187:224-233.
33. Alon, R., Rossiter, H., Wang, X.H., Springer, T.A. and Kupper, T.S. 1994. Distinct cell surface ligands mediate T lymphocyte attachment and rolling on P and E selectin under physiological flow. J. Cell Biol. 127:1485-1495.
34. Schriever, F., et al. 1997. Human T lymphocytes bind to germinal centers of human tonsils via integrin alpha4/VCAM-1 and LFA-1/ICAM-1 and -2. Eur. J. Immunol. 27:35-39.
35. Shimizu, Y., et al. 1991. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J. Cell Biol. 113:1203-1212.
36. van Kooyk, Y., van de Wiel-van Kemenade, E., Weder, P., Huijbens, R.J., and Figdor, C.G. 1993. Lymphocyte function-associated antigen 1 dominates very late antigen 4 in binding of activated T cells to endothelium. J. Exp. Med. 177:185-190.
37. Porter, J.C., and Hogg, N. 1997. Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters alpha4beta1- and alpha5beta1-mediated function. J. Cell Biol. 138:1437-1447.
38. Jones, D.A., Mcintire, L.V., Smith, C.W., and Picker, L.J. 1994. A two-step adhesion cascade for T cell endorhelial cell interactions under flow conditions. J. Clin. Invest. 94:2443-2450.
39. Berlin, C., et al. 1995. Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 80:413-422.
40. Johnston, B., Issekutz, T.B. and Kubes, P. 1996. The alpha 4-integrin supports leukocyte rolling and adhesion in chronically inflamed post-capillary venules in vivo. J. Exp. Med. 183:1995-2006.
41. Estess, P.E., Nandi, A., and Siegelman, M.H. 1999. IL-15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44 dependent pathway in vivo. J. Exp. Med. 190:9-19.
42. Yednock, T.A., et al. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 356:63-66.
43. Issekutz, A.C., and Issekutz, T.B. 1995. Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms. J. Exp. Med. 181:1197-1203.
44. Issekutz, T.B., and Issekutz, A.C. 1991. T lymphocyte migration to arthritic joints and dermal inflammation in the rat: differing migration patterns and the involvement of VLA-4. Clin. Immunol. Immunopathol. 61:436-447.
45. Yang, X.D., Karin, N., Tisch, R., Steinman, L., and McDevitt, H.O. 1993. Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc. Natl. Acad. Sci. USA. 90:10494-10498.
46. Issekutz, T.B., Miyasaka, M., and Issekutz, A.C. 1996. Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation. J. Exp. Med. 183:2175-2184.
47. Andersson, E.C., Christensen, J.P., Marker, O., and Thomsen, A.R. 1994. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J. Immunol. 152:1237-1245.
48. Reinhardt, P.H., Elliott, J.F., and Kubes, P. 1997. Neutrophils can adhere via alpha(4)beta(1)-integrin under flow conditions. Blood. 89:3837-3846.
49. Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G., and Janeway, C.A., Jr. 1993. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57-68.
50. van Dinther-Janssen, A.C., et al. 1991. The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J. Immunol. 147:4207-4210.
51. Laffon, A., et al. 1991. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J. Clin. Invest. 88:546-552.
52. Baron, J.L., Reich, E.P., Visintin, I., and Janeway, C.A., Jr. 1994. The pathogenesis of adoptive mutine autoimmune diabetes requires an interaction between alpha 4-integrins and vascular cell adhesion molecule-1. J. Clin. Invest. 93:1700-1708.
53. Catalina, M.D., Estess, P., and Siegelman, M.H. 1999. Selective requirements for leukocyte adhesion molecules in models of acute and chronic cutaneous inflammation: participation of E- and P-but not L-selectin. Blood. 93:580-589.
54. Ferguson, T.A., and Kupper, T.S. 1993. Antigen-independent processes in antigen-specific immunity. A role for alpha 4 integrin. J. Immunol. 150:1172-1182.
55. Chisholm, P.L., Williams, C.A., Lobb, R.R. 1993. Monoclonal antibodies to the integrin alpha-4 subunit inhibit the murine contact hypersensitivity response. Eur. J. Immunol. 23:682-688.
56. Silber, A., et al. 1994. Recruitment of lymphocytes during cutaneous delayed hypersensitivity in nonhuman primates is dependent on E-selectin and vascular cell adhesion molecule 1. J. Clin. Invest. 93:1554-1563.
57. Issekutz, T.B. 1993. Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation. Am. J. Pathol. 143:1286-1293.
58. Bargatze, R.F., Jutila, M.A., and Butcher, E.C. 1995. Distinct roles of L-selectin and integrins a4b7 and LFA-1 in lymphocyte homing to Peyer's Patch-HEV in situ: the multistep model confirmed and refined. Immunity. 3:99-108.
59. Luscinskas, E.W., Ding, H., and Lithtman, A.H. 1995. P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4-T lymphocytes on tumor nectosis factor alpha-activated vascular endothelium under flow. J Exp. Med. 181:1179-1186.
60. Jung, U., and Ley, K. 1999. Mice lacking tun or all three selectins demonstrate overlapping and distinct functions tor each selectin. J. Immunol. 162:6755-6762.
61. Oppenheimer-Marks, N., Davis, L.S., Bogue, D.T., Ramberg, J., and Lipsky, P.E. 1991. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J. Immunol. 147:2913-2921.
62. Hwang, S.T., et al. 1996. GlyCAM-1, a physiologic ligand for L-selectin, activates beta 2 integrins on naive peripheral lymphocyte. J. Exp. Med. 184:1343-1348.
63. Warnock, R.A., Askari, S., Butcher, E.C., and von Andrian, U.H. 1998. Molecular mechanisms of lymphocyte homing to peripheral lymphnodes. J. Exp. Med. 187:205-216.